Observing that diabetes was reliably induced when alloxan was administered on day 2 (mostly with BGLs exceeding 300 mg/dl on day 1), starting from experimental round 4, diabetes induction was shifted to 3 days before transplantation to alleviate the efforts in blood glucose management and insulin administration. The gene discussed is INS; the disease is diabetes mellitus.